blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1104300

EP1104300 - CARBOXYLIC ACIDS AND ISOSTERES OF HETEROCYCLIC RING COMPOUNDS HAVING MULTIPLE HETEROATOMS FOR VISION AND MEMORY DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.04.2003
Database last updated on 11.09.2024
Most recent event   Tooltip15.04.2003Application deemed to be withdrawnpublished on 28.05.2003  [2003/22]
Applicant(s)For all designated states
GPI NIL Holdings, Inc.
222 Delaware Avenue
Wilmington, DE 19899 / US
[2001/23]
Inventor(s)01 / ROSS, Douglas, T.
316 South Main Street
North Wales, PA 19454 / US
02 / SAUER, Hansjorg
10617 Lorain Avenue
Silver Spring, MD 20901 / US
03 / HAMILTON, Gregory, S.
6501 Frederick Road
Catonsville, MD 21228 / US
04 / STEINER, Joseph, P.
3179 Jupiter Island Court
Mt. Airy, MD 21771 / US
 [2001/38]
Former [2001/23]01 / ROSS, Douglas, T.
316 South Main Street
North Wales, PA 19454 / US
02 / SAUER, Hansjorg
10617 Lorain Avenue
Silver Spring, MD 20901 / US
03 / HAMILTON, Gregory, S.
6501 Frederick Road
Catonsville, MD 21228 / US
04 / STEINER, Joseph, P.
4150 Louisville Road
Finksburg, MD 21048 / US
Representative(s)Merkle, Gebhard
Ter Meer Steinmeister & Partner
Patentanwälte mbB
Mauerkircherstrasse 45
81679 München / DE
[N/P]
Former [2001/23]Merkle, Gebhard
TER MEER STEINMEISTER & PARTNER GbR, Patentanwälte, Mauerkircherstrasse 45
81679 München / DE
Application number, filing date99939731.812.08.1999
[2001/23]
WO1999US18238
Priority number, dateUS1998013447614.08.1998         Original published format: US 134476
[2001/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0009106
Date:24.02.2000
Language:EN
[2000/08]
Type: A2 Application without search report 
No.:EP1104300
Date:06.06.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 24.02.2000 takes the place of the publication of the European patent application.
[2001/23]
Search report(s)International search report - published on:EP12.10.2000
ClassificationIPC:A61K31/41, A61K31/40, A61K31/44, A61K31/42, A61K31/415, C07D263/04, C07D207/16, A61P27/02
[2001/23]
CPC:
A61K31/675 (EP,US); A61K31/00 (EP,US); A61K31/4164 (EP,US);
A61K31/4172 (EP,US); A61K31/4178 (EP,US); A61K31/421 (EP,US);
A61K31/422 (EP,US); A61K31/426 (EP,US); A61K31/427 (EP,US);
A61K31/4439 (EP,US); A61P27/02 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/23]
Extension statesAL29.12.2000
LT29.12.2000
LV29.12.2000
MK29.12.2000
RO29.12.2000
SI29.12.2000
TitleGerman:CARBONSÄURE UND ISOSTERE VON HETEROZYCLISCHEN RINGVERBINDUNGEN MIT MEHREREN HETEROATOMEN ZUR BEHANDLUNG VON SICHT- UND GEDÄCHNISSSCHWÄCHEN[2001/23]
English:CARBOXYLIC ACIDS AND ISOSTERES OF HETEROCYCLIC RING COMPOUNDS HAVING MULTIPLE HETEROATOMS FOR VISION AND MEMORY DISORDERS[2001/23]
French:ACIDES CARBOXYLIQUES ET ISOSTERES DE COMPOSES A NOYAU HETEROCYCLIQUE POSSEDANT PLUSIEURS HETEROATOMES ET DESTINES A DES TROUBLES DE LA VISION ET DE LA MEMOIRE[2001/23]
Entry into regional phase29.12.2000National basic fee paid 
29.12.2000Designation fee(s) paid 
29.12.2000Examination fee paid 
Examination procedure22.11.1999Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.12.2000Examination requested  [2001/23]
26.04.2001Amendment by applicant (claims and/or description)
09.07.2002Despatch of a communication from the examining division (Time limit: M04)
20.11.2002Application deemed to be withdrawn, date of legal effect  [2003/22]
30.12.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/22]
Fees paidRenewal fee
29.12.2000Renewal fee patent year 03
21.08.2002Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0044134  (UNIV FLORIDA [US]) [X] 1-7,10,12-19,21 * abstract *;
 [X]GB2155331  (FLORIDA UNIVERSITY OF) [X] 1-7,10,12-19,21 * claims 1,3,4 *;
 [X]EP0444546  (MOCHIDA PHARM CO LTD [JP]) [X] 1-7,10,12-19,21 * abstract * * page 2, lines 36-58 * * page 5, lines 6-40 *;
 [X]WO9513811  (BYK NEDERLAND BV [NL], et al) [X] 1-6,12-17 * abstract *;
 [X]WO9640633  (GUILFORD PHARM INC [US]) [X] 1-22 * abstract * * page 31, line 24 - page 32, line 9; examples 1-15 *;
 [X]WO9727180  (VERTEX PHARMA [US], et al) [X] 1-7,10,12-19,21 * abstract * * page 117, lines 3-15; examples 13,20,21,27,40,106,107,109-111; claims 1,18,19 *;
 [X]WO9813355  (GUILFORD PHARM INC [US]) [X] 1-8,10-19,21,22 * abstract * * page 15, line 1 - page 21, line 26 * * page 25, line 23 - page 26, line 11; examples 1,2; claims 1-35 *;
 [X]WO9813343  (GUILFORD PHARM INC [US]) [X] 1-8,11-19 * page 12, line 9 - page 14, line 4 * * page 22, line 14 - page 27, line 8 * * page 31, lines 3-17 *;
 [X]WO9829117  (GUILFORD PHARM INC [US]) [X] 1 * abstract * * page 18, line 12 - page 24, line 7 * * page 50, lines 3-17 *;
 [XP]WO9855090  (GUILFORD PHARM INC [US]) [XP] 12-19,21,22 * abstract * * page 12, line 23 - page 15, line 12 * * page 24, line 19 - page 26, line 13; table II * * page 26, line 25 - page 28, line 20; table III * * page 29, line 1 - page 34, line 17; table IV * * page 35, line 1 - page 36, line 23; table V * * page 37, line 15 - page 38, line 23 * * page 42, line 10 - page 51, line 18 * * page 53, line 1 - page 68, line 13 * * page 74, line 35 - page 89, line 26 * * page 96, lines 10-25; examples 4,5; claims 3,4 *;
 [PX]WO9906390  (ATHENA NEUROSCIENCES INC [US], et al) [PX] 1-7,10,12-19,21 * page 4, lines 13-26; tables IA,IB * * page 161, line 26 - page 162, line 5 * * page 165, lines 10-23 * * examples 11-17,25,26,29-31,36,49,51,52,54,55,59-61,64; claims 71,73,76,78,79,84,85,88,90-92,95,109,111; table II * * examples 147,161,164,167-176,181,185-191,195-198,201-222 * * examples 225,228-239,242,249-253,255,257-264,266 * * examples 267,270-273,275,279,283-287,289-292,299,300; table IIIA * * examples 334,335; claims 1-34 *;
 [PX]WO9914998  (AMGEN INC [US], et al) [PX] 12-22 * page 188, line 5 - page 200, line 8; examples 4,5,23; table XLIV * * page 283 - page 284; claims 1-177 *;
 [PX]EP0930067  (PFIZER PROD INC [US]) [PX] 1-7,10,12-19,21 * claims 1,4 *;
 [E]WO9962888  (GUILFORD PHARM INC [US], et al) [E] 1-22 * abstract * * page 4, line 13 - page 10, line 9 * * compounds 1-220; page 24, line 35 - page 25, line 14; example 1; claims 1-13,65-71 *;
 [E]WO9962487  (GUILFORD PHARM INC [US]) [E] 12-19,21,22 * abstract *;
 [E]WO0004005  (ONO PHARMACEUTICAL CO [JP], et al) [E] 12-19 * page 108; tables 1-40 * * pages 124-132 * * page 144 * * page 146 * * pages 148-150 ** claims 1-15 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.